BAR HARBOR — Kenneth H. Fasman, a biomedical researcher whose work in the academic, nonprofit and business sectors has made him a leader in scientific collaborative research management, has been named The Jackson Laboratory’s new vice president for strategic initiatives.
In announcing the newly created position, JAX President and Chief Executive Officer Edison Liu noted that the laboratory has dramatically expanded its collaborative research projects in the U.S. and abroad and its facilities, including the new Jackson Laboratory for Genomic Medicine in Farmington, Conn.
Over the last 15 years, Fasman has built many connections with JAX, serving on the laboratory’s scientific advisory board and advising the Genetic Resource Sciences group. He currently serves on the JAX board of scientific counselors.
“Ken is uniquely qualified to help us to drive the laboratory’s long-term growth while accelerating our mission to advance human health. He brings deep experience in science project management, understands organizational dynamics and is familiar with our unique academic culture and community.” Liu said. “In his new role, he will focus on key strategic initiatives, such as the collaboration with Beth Israel Deaconess Medical Center, which Ken helped us to orchestrate, as well as integrate our campuses in Maine, Connecticut and California.”
Fasman joins the laboratory from the Adelson Medical Research Foundation in Needham, Mass., where he has been vice president and chief scientific officer since 2008. From 1998 to 2008, he worked with the international pharmaceutical giant AstraZeneca, rising to director of drug development strategy and performance.
From 1992 to 1998, Fasman worked on the human genome project at the Johns Hopkins University School of Medicine and later at the Whitehead Institute/MIT Center for Genome Research. While earning his doctorate in biomedical engineering from Hopkins, Fasman cofounded a laboratory software and systems design consulting firm, BME Systems Inc.